Skip to content
drillr.ai

WW

WW International, Inc.

NASDAQ · USConsumer CyclicalPersonal Products & Services
$14.87+2.06%

Price as of Jul 20, 2026

WW news

WW International, Inc. news

A server-rendered, paginated timeline of the latest available company news.

  1. Weight Watchers to Support the American Heart Association’s Healthy Living BEYOND Weight Study

    NEW YORK, June 22, 2026 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ: WW) (“Weight Watchers”), the global leader in science-backed weight health, today announced that it is continuing its long-standing support of the American Heart Association by engaging members to enroll and participate in the Healthy Living BEYOND Weight™ Study. The American Heart Association’s Healthy Living BEYOND Weight Study is one of the most inclusive efforts to understand the lived experiences and long-term healt

    Globe Newswire ·

  2. Weight Watchers and CheqUp Expand Partnership To Deliver Holistic Support for Weight Health in the UK

    The collaboration brings clinical and behavioural weight management together, offering UK members a more integrated path to sustainable weight loss. CheqUp becomes the dedicated partner for weight-loss treatment, including access to CheqUp’s clinical service in the UK, mirroring the integrated clinical model in the US. NEW YORK, June 16, 2026 (GLOBE NEWSWIRE) -- WW International, Inc (Nasdaq: WW) (“Weight Watchers”), the global leader in science-backed weight management, and CheqUp, the UK’s l

    Globe Newswire ·

  3. Weight Watchers Expands Med+ With Access to New Ozempic® pill (semaglutide)

    NEW YORK, May 01, 2026 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ: WW) (“Weight Watchers”), the global leader in science-backed weight management, announced that it will begin offering access to Novo Nordisk’s now available Ozempic(® )pill (semaglutide) through its Med+ offering and affiliated medical groups. The addition will give members a once-daily GLP-1 option for adults living with type 2 diabetes, further expanding Weight Watchers’ growing portfolio of oral GLP-1 treatments availa

    Globe Newswire ·

  4. Weight Watchers Schedules First Quarter 2026 Earnings Conference Call

    NEW YORK, April 23, 2026 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ: WW) (“Weight Watchers” or the “Company”) will release its results for the first quarter 2026 ended March 31, 2026, before market open on Thursday, May 7, 2026. Weight Watchers will host a conference call to discuss results at 8:30 a.m. ET the same day. The webcast of the conference call will be available on the Company’s corporate website, corporate.ww.com, under Events and Presentations. A replay of the webcast will b

    Globe Newswire ·

  5. Weight Watchers Appoints Proven Healthcare Executive Heather Thiltgen to Board of Directors

    NEW YORK, April 20, 2026 (GLOBE NEWSWIRE) -- WW International, Inc. (Nasdaq: WW) (“Weight Watchers” or the “Company”), the global leader in science-backed weight management, today announced that it has appointed Heather Thiltgen to the Company’s Board of Directors, effective April 20, 2026. Ms. Thiltgen currently serves as the President of Presbyterian Health Plan and previously served as President & CEO of WellSense Health Plan. As Weight Watchers expands its integrated weight health platform,

    Globe Newswire ·

  6. Weight Watchers Appoints Lisa Gavales and Sue Gove to Board of Directors

    NEW YORK, April 07, 2026 (GLOBE NEWSWIRE) -- WW International, Inc. (Nasdaq: WW) (“Weight Watchers” or the “Company”), the global leader in science-backed weight management, today announced that it has appointed accomplished executives, Lisa Gavales and Sue Gove, as independent members of the Company’s Board of Directors, effective April 7, 2026. Ms. Gavales and Ms. Gove will serve as directors until the Company’s 2026 annual meeting of shareholders and are expected to stand for election at the

    Globe Newswire ·

  7. Weight Watchers Announces Leadership Transition and Board Updates

    Office of the CEO Established to Oversee Business Operations Board Forms Transition Committee and Commences CEO Search NEW YORK, April 03, 2026 (GLOBE NEWSWIRE) -- WW International, Inc. (Nasdaq: WW) (“Weight Watchers” or the “Company”), the global leader in science-backed weight management, today announced leadership and governance changes, including the establishment of an Office of the CEO and the formation of a new Transition Committee of the Board of Directors (“the Board”). These actions f

    Globe Newswire ·

  8. Weight Watchers Announces Best in Market Self-Pay Wegovy® Pricing for Med+ Members and the Launch of Preferred Subscription Pricing for Wegovy via NovoCare®

    NEW YORK, March 31, 2026 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ: WW) (“Weight Watchers”), the global leader in science-backed weight health, today announced that eligible Weight Watchers Med+ members will have access to subscription pricing for Wegovy® that significantly reduces out-of-pocket costs and is a result of expanded collaboration between Weight Watchers and Novo Nordisk. The new subscription offer gives Weight Watchers Med+ members access to the lowest available self-pay pr

    Globe Newswire ·

  9. Weight Watchers Schedules Fourth Quarter and Full Year 2025 Earnings Conference Call

    NEW YORK, Feb. 27, 2026 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ: WW) (“Weight Watchers” or the “Company”) will release its results for the fourth quarter and full year 2025 ended December 31, 2025 before market open on Monday, March 16, 2026. Weight Watchers will host a conference call to discuss results at 8:30 a.m. ET the same day. The webcast of the conference call will be available on the Company’s corporate website, corporate.ww.com (https://www.globenewswire.com/Tracker?data=uTJ

    Globe Newswire ·